As of September 1, 2025, Dr. Pugh will be leaving Anova Cancer Care Specialists. We are deeply grateful for the compassionate care, expertise, and dedication Dr. Pugh has provided to our patients and their families during his time with us. His commitment to excellence has made a meaningful impact, and we wish him every success in the next chapter of his career.
At the same time, we are pleased to welcome Dr. Ben Fischer-Valuck, who joined Anova in August. Dr. Fischer-Valuck is a board-certified radiation oncologist with extensive experience in advanced treatment techniques for prostate, lung, breast, and gastrointestinal cancers. He has particular expertise in prostate cancer care, with a focus on image-guided radiation therapy, stereotactic body radiation therapy (SBRT), and other leading-edge approaches that offer patients highly precise, effective, and personalized treatment options.
CyberKnife continues to be an excellent treatment choice for many men with prostate cancer because it delivers highly targeted, precise radiation with minimal damage to surrounding healthy tissue. This advanced approach allows for shorter treatment courses, fewer side effects, and excellent long-term cancer control. Dr. Fischer-Valuck’s expertise in CyberKnife and other leading-edge therapies builds on Anova’s long-standing reputation as a leader in prostate cancer treatment. Patients can feel confident knowing that they will continue to have access to the most advanced and effective treatment options available.
Dr. Fischer-Valuck is dedicated to guiding patients through their cancer journey with compassion, clear communication, and evidence-based care. We are excited to welcome him to the Anova team and confident that his skills and patient-centered approach will further strengthen our mission of delivering the highest level of care and support.
